Kneu Health secures £4.2m seed funding to scale neurology care platform
The round was co-led by Oxford Science Enterprises and Cedars-Sinai to accelerate US expansion.
Kneu Health develops a precision neurology platform that tracks motor, speech and cognitive changes via a smartphone application. The company builds population scale datasets to help manage neurodegenerative conditions such as Parkinson and dementia.
Kneu Health has secured £4.2m in an oversubscribed seed round co-led by Oxford Science Enterprises and Cedars-Sinai. Additional participation came from Social Impact Enterprises, JIMCO, G.K. Goh Ventures and SXSW London.
The capital will be directed towards accelerating expansion in the United States by scaling Parkinson deployments, growing commercial capacity, publishing outcomes data, and advancing dementia monitoring.
The company has established a presence in several prominent American medical ecosystems and its technology is already adopted across major United States health systems and NHS trusts.
From the founder
"We’ve spent the last two years proving that remote monitoring can transform neurological care. Clinicians are getting clearer insight without added workload, patients no longer face months of uncertainty between visits, and gain confidence that changes will be recognized rather than missed."
Caroline Cake
co-founder and CEO at Kneu Health
Investor perspective
"Neurology has had plenty of algorithms. What it has lacked is longitudinal signal that clinicians can trust and act on inside real workflows. Kneu has turned everyday phone interactions into a clinically governed measurement layer that scales across populations without new hardware or staffing. With evidence emerging on both sides of the Atlantic, Kneu is laying the foundation for a reference dataset and operating platform in Parkinson’s and dementia that raises standards of care while finally making the economics work for hospitals and payers."
Schoppig Schoppig
Health Tech Investment Principal, Oxford Science Enterprises
Use of funds
- 01Expand into international markets
- 02Invest in sales and marketing
- 03Fund research and development
Investors
Schoppig Schoppig
Oxford Science Enterprises
Nirdesh Gupta
Cedars-Sinai
Social Impact Enterprises
JIMCO
G.K. Goh Ventures
SXSW London
Categories
About the company
Kneu Health
A precision neurology platform for tracking Parkinson and dementia via smartphones.